Mangoceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022
Cash & Equivalents	0.76	0.7
Cash & Cash Equivalents	0.76	0.7
Cash Growth	8.02%	-
Inventory	0.02	0
Other Current Assets	0.04	-0.01
Total Current Assets	0.82	0.69
Property, Plant & Equipment	0.22	0.29
Other Long-Term Assets	0.02	0.02
Total Long-Term Assets	0.23	0.31
Total Assets	1.05	1
Accounts Payable	0.14	0.03
Current Debt	0.06	0.22
Other Current Liabilities	0.01	0
Total Current Liabilities	0.21	0.26
Long-Term Debt	0.06	0.13
Total Long-Term Liabilities	0.06	0.13
Total Liabilities	0.28	0.39
Total Debt	0.13	0.35
Debt Growth	-63.53%	-
Retained Earnings	-11.23	-2.02
Shareholders' Equity	0.77	0.61
Net Cash / Debt	0.63	0.35
Net Cash / Debt Growth	80.80%	-
Net Cash Per Share	0.04	0.03
Working Capital	0.61	0.43
Book Value Per Share	0.05	0.06

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).